PMH38 THE ECONOMIC IMPACT OF GENERIC SWITCHING FOR PATIENTS WITH MAJOR DESPRESSIVE DISORDER (MDD) TREATED WITH ESCITALOPRAM OR A PATENTED SSRI

Autor: Lauzon, V, Kaltenboek, A, Yu, AP, Ramakrishnan, K, Marynchenko, M, Wu, EQ, Ben-Hamadi, R, Erder, MH, Bose, A
Zdroj: In Value in Health 2009 12(3):A179-A179
Databáze: ScienceDirect